Fresh data compiled by IT Juzi points to a sharp change in how capital is being deployed across China’s embodied intelligence sector. The report, based on figures through Aug. 20, 2026, shows 425 startups are now active in the field, with 321 of them — or 75% — founded between 2023 and 2026. Financing has accelerated just as quickly: the sector logged 466 funding deals worth 124.51 billion yuan in the first eight months of 2026 alone, up 11.6 times from the total raised in 2023. The backdrop is Unitree Technology’s Aug. 19 listing on Shanghai’s STAR Market, where the company priced shares at 150.8 yuan and reached a first-day market value of 341.8 billion yuan, with a price-to-earnings ratio above 219. Yet the industry’s own leaders are still cautious. Speaking at the World Robot Conference on Aug. 20, Unitree founder Wang Xingxing said embodied intelligence may be 2 to 3 years away from its “ChatGPT moment” in an optimistic case, or 5 to 10 years away in a slower scenario. IT Juzi’s dataset suggests venture money is no longer focused only on humanoid robot makers. By deal count, embodied brain systems have overtaken humanoid robots as the hottest sub-sector in 2026, while large-ticket funding still clusters around leading full-machine manufacturers. The report also highlights a heavy concentration of startups in Beijing, Guangdong and Shanghai, rising participation from 853 investment institutions, and a founder base dominated by Tsinghua-linked entrepreneurs.

A Late Post report cited by PANews paints a crowded and overheated embodied AI market in China, where capital has rushed into humanoid robots, dexterous hands, data collection, joint modules, and tactile sensors long before the sector has established durable industrial demand or a broadly accepted valuation framework. In the first half of 2026 alone, domestic embodied AI financing exceeded RMB 90 billion, and 22 companies were valued above RMB 10 billion, according to IT Juzi. Yet field observations described in the report show many robots still move too slowly for real factory deployment, while some revenue is tied to research, education, data collection loops, channel stocking, or related-party structures rather than large-scale end-user adoption. Unitree’s listing has become the market’s closest thing to a public benchmark. Morgan Stanley said more than 10,000 embodied robots were actually shipped in China last year, with Unitree accounting for 5,215 units. Its 2025 revenue reached RMB 1.699 billion, but the report notes that more than 70% of revenue as of last September came from research and education, and less than 10% came from industry applications. The broader question now is whether public markets will price Unitree as a high-growth embodied AI platform with future "brain" capabilities, or more like a strong engineering and hardware company. That answer may shape how long today’s private-market valuations can hold.

Unitree Technology’s upcoming IPO has put brokerage involvement under the spotlight on both sides of the deal. According to a report republished by MarsBit and sourced from IT Juzi, at least 12 brokerages had already gained exposure to Unitree before listing, largely through funds and alternative investment channels rather than direct shareholding. Once the subscription phase opened, another 34 brokerages and their asset-management units joined the offline bookbuilding process. The report highlighted CITIC Securities in particular, saying the firm is positioned to profit from the transaction in four ways at once: as an early pre-IPO investor through Jingshi Growth and Zhongzheng Investment, as the mandatory sponsor follow-on investor, as the sponsor and underwriter collecting about RMB 145 million in fees, and as the manager of the employee strategic placement asset-management plan. It also said Unitree’s founder Wang Xingxing contributed RMB 15 million to that strategic placement arrangement. The article argues that overlapping primary- and secondary-market exposure makes the brokerage system’s overall stake in Unitree larger than what direct holdings alone suggest. With Unitree priced at 219 times earnings, a market value of RMB 60.9 billion, fundraising of more than RMB 6 billion, and expected first-half 2026 revenue of RMB 1.05 billion to RMB 1.13 billion, the report frames the deal as a shared-bet structure in which fees, locked capital, and valuation risk are tied to the same project.

China’s embodied AI sector has moved from a funding shortage to a capital management problem. A lengthy report carried by MarsBit, citing Leo Zhang ToB Notes and written by Zhang Shenyu, describes how startups flush with cash are now exposing opposite but equally damaging habits: reckless spending and excessive frugality. One investor said a well-known embodied AI company paid RMB 100 million in cash and equity for just a few minutes of gala exposure without board or shareholder approval. The campaign failed to show the value of its product, the investor said, and the spending reduced the firm’s R&D ratio enough to hit a Hong Kong listing rule threshold, potentially forcing it to re-queue for an IPO attempt. At the other extreme, another company reportedly had more than RMB 100 million on its books but refused to send hardware staff to oversee production lines in person, choosing remote video acceptance for more than 100 robots. A potential investor later learned of that decision and dropped the financing. The report argues that with hundreds of billions of yuan flowing into embodied AI, founders and investors alike are struggling to measure what spending should look like in a sector defined by heavy costs in talent, compute, data and hardware, but few mature benchmarks for judging whether the money is producing real progress.

A new report from IT Juzi says China added 67 unicorns in the first half of 2026, with AI and embodied intelligence companies accounting for more than half of the total. The research then examined all 107 unicorns currently on its list in China’s AI and robotics/embodied intelligence sectors, tracing every investor that appeared in seed, angel and angel-plus rounds. As of July 2026, nearly 300 institutions had backed at least one unicorn at the angel stage, according to the report. By total count, Sequoia China ranked first with 11 angel-round hits, followed by GL Ventures and ZhenFund with nine each. But when the sample is narrowed to new embodied intelligence bets made after 2022, MiraclePlus, Linear-like early-stage specialist Lanchi Ventures, and SEE Fund stand out for concentrated exposure. The report also breaks down how those firms operated. MiraclePlus used a high-volume accelerator-style model with standardized checks and small initial tickets; Lanchi built founder-sourcing channels through its BuMing camp and AGI Pioneer Club; SEE Fund leaned on a tight engineering network around Tsinghua-linked founders while building positions across the embodied intelligence supply chain. IT Juzi argues that U.S. dollar funds still moved earlier overall, while many RMB funds only began entering the sector at scale after 2025.

Data from IT Juzi shows that as of July 1, 2026, China had 517 unicorn companies with a combined valuation of about $2.39 trillion. In the first half of 2026 alone, 67 new unicorns were added, setting the highest semiannual figure in nearly five years. The new cohort was led by artificial intelligence and robotics, which together accounted for more than 53% of all additions. Beijing, Shanghai, Shenzhen, and Hangzhou hosted 76.1% of the newly added unicorns, underscoring an even stronger concentration in top-tier innovation hubs. DeepSeek topped the new list with an estimated valuation of $61.5 billion, highlighting how large language models and embodied intelligence are increasingly moving from technological promise to industrial deployment. The report also points to a widening split between fast-rising AI startups, often backed by star founders or spin-offs from major tech firms, and slower-building hard-tech companies in semiconductors, biotech, and advanced manufacturing.